-
Sorokin M, Mansfield PR.
Revealing
all.
Lancet Infect Dis. 2003 May;3(5):270-1.
-
Mansfield,
P. R.; Lexchin, J.; Vitry, A.; Doecke, C. J., and Svensson, S. Drug
advertising in medical journals. Lancet. 2003 Mar 8; 361(9360)879.
-
Juredini
JN, Mansfield PR. Avoiding competing interests. 26 Dec 2002 http://bmj.com/cgi/eletters/325/7377/1375#28210
-
Mansfield
P, Evans A. Costs are important but it's
medicines that save lives Australian Financial Review 02/02/2002
-
Vlassov
V, Mansfield P, Lexchin J, Vlassova A. Do drug advertisements in Russian
medical journals provide essential information for safe prescribing?
West J Med. 2001 Jun;174(6):391-4.
-
Juredini
J, Mansfield P. Does drug promotion adversely influence doctors’ abilities
to make the best decisions for patients? Australasian Psychiatry
2001;9:2:95-99
-
Mansfield
P. Pushing expensive new drugs. Consuming Interest 2001 86 (Southern) Summer 27-29
-
Mansfield
P, Juredini J. Giving doctors the treatment. Health
Matters (UK) issue 43 (Northern) Winter 2000/01 www.healthmatters.org.uk/stories/mansfield.html
- Mansfield
PR, Lexchin J. Networking for scientific integrity in drug promotion. Essential Drugs
Monitor 1997; 24: 5
for that edition of the EDM as a pdf file in
english, français or español click here then click where appropriate under EDM 24
Our article is on page 5
- Mansfield PR.
MaLAM, a medical lobby for appropriate marketing of pharmaceuticals. Med J Aust 1997; 167:
590-592
- Mansfield
PR. How does
pharmaceutical company promotion affect prescribing? Poster presented at ICIUM April
1997
- Vitry A,
Mansfield P. Drug advertisements in medical journals. Lancet 1997; 350: 1477
- Vitry A,
Mansfield P. Promotion of Coversyl by Servier. Lancet 1996; 347: 1411
- Mansfield P.
Reprimanded. Australian Doctor. 27 September 1996; 18
- Mansfield P.
Campaign to combat misleading promotion. INRUD News 1996; 6: 2: 3
- Vitry A.
Pharmaceutical promotion: Drug advertising affects your prescribing. Australian Prescriber
1996; 19: 4: 103
- Mansfield P.
Are Pharmaceutical customers prey or partners? Scrip magazine 1995: June: 14-5
- Mansfield P.
Look at the fine print. Australian Doctor 1995; 30 June
- Mansfield
PR. Encouraging trustworthy drug advertising. Essential Drugs Monitor 1994; 17: 6-7.
- Mansfield P,
Mashford ML. Use of amoxycillin trihydrate/potassium clavulanate. Australian Prescriber
1994; 17: 3: 55.
- Mansfield
PR. Pharmaceutical promotion. Australian Prescriber 1993; 16: 4: 89.
- Mansfield
PR. Pharmaceutical promotion. Australian Prescriber 1993; 16: 3: 60.
- Chetley A,
Mintzes B. ed. Promoting health or pushing drugs? Amsterdam: Health Action International.
1992.
- Harvey K,
Mansfield P. Drug promotion: the critical approach. Australian Prescriber 1991; 14: supp.
1: 34-6.
- Mansfield
PR. Encouraging drug companies to be honest. Australian Prescriber 1991; 14: 4: 74.
- Mansfield
PR. Classifying improvements to drug marketing and justifications for claims of efficacy.
International Journal of Risk and Safety in Medicine. 1991; 2: 171-184.
- Mansfield
PR. MaLAM's open letter to industry. Scrip 1989; 1457: 22-23.
- Wade VA,
Mansfield PR, McDonald PJ. Drug companies' evidence to justify advertising. Lancet 1989;
8674: 1261-4.
- Mansfield
PR. MaLAM calls for better drug information. Essential Drugs Monitor 1989; 8: 9.
- Mansfield
PR. Drug advertising. Lancet 1989; i: 1137.
- International
Drug Marketing Code. Lancet 1988; i: 988.
- International
Medical Advertising. Lancet 1988; i: 350.
- MLAM. Lancet
1984; ii: 861.
